| Application no. and date | 13835019.4 (espacenet) (Federated) (European Patent Register), 20130830 | | Patent/reg. no. and date | DK/EP 2892535, 20210922 | | Publication date | 20150715 | | Priority no. and date | US 201261696375 P, 20120904 | | EP pub. no. and date |
EP 2892535 20150715 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | BT/GP/165490 | | Inventor | LAQUERRE, Sylvie, c/o GlaxoSmithKline
Global Patents Department
709 Swedeland Road
King of Prussia, Pennsylvania 19406, US,
LEBOWITZ, Peter F., c/o GlaxoSmithKline
Global Patents Department
Five Moore Drive
P. O. Box 13398
Research Triangle Park, North Carolina 27709, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61K 31/519 (2006.01) , A61P 35/00 (2006.01) | | Title | Fremgangsmåde til adjuverende cancerbehandling | | Int. application no. | US2013057432 | | Int. publication no. | WO2014039375 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
